Deaths due to illicit ketamine use increased 20-fold since 2014, increasingly in polydrug settings, raising doubts over whether single-substance drug policies can reduce harms, King’s College London reported in Deaths following illicit ketamine use in England, Wales and Northern Ireland 1999-2024.


